# Iran (Islamic Republic of) Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Iran (Islamic Republic of) HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Iran (Islamic Republic of) (IRN) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $255.1M - Products: 33 - Buyer markets: 29 - Average CAGR: +7.8% - Global sector size: $497.8B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $301.0B | $6.9M | $113.7B | -2.3% | 20 | +0.0% | | HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $55.3B | $11.6M | $24.9B | +60.0% | 9 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $20.1B | $180.8K | $13.1B | +7.1% | 10 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $18.4B | $24.7M | $10.4B | +9.7% | 4 | +0.1% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $9.1B | $763.5 | $7.2B | -36.0% | 4 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $15.3B | $93.9K | $7.0B | +3.6% | 4 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $11.9B | $205.3K | $6.4B | +12.4% | 4 | +0.0% | | HS 290243 - Cyclic hydrocarbons: p-xylene | $8.5B | $58.9M | $6.2B | +26.5% | 1 | +0.7% | | HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $6.7B | $1.6K | $5.5B | +5.1% | 2 | +0.0% | | HS 330300 - Perfumes and toilet waters | $8.5B | $22.0K | $5.0B | +21.4% | 3 | +0.0% | | HS 290220 - Cyclic hydrocarbons: benzene | $4.7B | $13.1M | $4.3B | -3.7% | 2 | +0.2% | | HS 290110 - Acyclic hydrocarbons: saturated | $2.0B | $25.8K | $3.8B | +51.8% | 1 | +0.0% | | HS 300220 - Vaccines: for human medicine | $4.6B | $89.4K | $3.4B | -11.8% | 2 | +0.0% | | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $3.5B | $1.2 | $3.2B | -98.5% | 1 | +0.0% | | HS 290121 - Acyclic hydrocarbons: unsaturated, ethylene | $1.8B | $1.1K | $2.4B | -14.7% | 1 | +0.0% | | HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $3.1B | $5.7 | $2.1B | -24.4% | 1 | +0.0% | | HS 290531 - Alcohols: acyclic, diols: ethylene glycol (ethanediol) | $3.2B | $135.0M | $2.0B | +16.7% | 1 | +4.2% | | HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $178.6K | $1.9B | +62.6% | 1 | +0.0% | | HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $0.1 | $1.4B | -39.4% | 1 | +0.0% | | HS 291736 - Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $1.6B | $142.5K | $1.4B | +4.3% | 1 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $172.4 | $1.4B | -22.8% | 1 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $1.1B | $2.4K | $1.1B | +1.0% | 1 | +0.0% | | HS 281820 - Aluminium oxide: other than artificial corundum | $2.3B | $260.3K | $1.1B | +160.6% | 1 | +0.0% | | HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $5.0K | $1.1B | -3.6% | 1 | +0.0% | | HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.0B | $2.2M | $1.0B | +2.6% | 1 | +0.1% | | HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $270.0K | $989.6M | +57.4% | 1 | +0.0% | | HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $2.3 | $981.1M | -25.4% | 1 | +0.0% | | HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $281.5K | $870.8M | +12.3% | 1 | +0.0% | | HS 310520 - Fertilizers, mineral or chemical: containing the three fertilizing elements nitrogen, phosphorus and potassium | $589.9M | $48.8 | $805.3M | -50.8% | 1 | +0.0% | | HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $53.8K | $803.2M | +3.1% | 1 | +0.0% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $956.7M | $43.5K | $799.8M | -16.2% | 1 | +0.0% | | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $734.9M | $25.6K | $798.7M | -1.9% | 1 | +0.0% | | HS 280120 - Iodine | $525.7M | $771.8K | $797.6M | -0.6% | 1 | +0.4% | ## Best markets - Switzerland, Liechtenstein (CHE): $36.6B calculated opportunity across 4 products. - China (CHN): $34.2B calculated opportunity across 11 products. - Germany (DEU): $32.9B calculated opportunity across 13 products. - USA, Puerto Rico and US Virgin Islands (USA): $21.7B calculated opportunity across 2 products. - Netherlands (NLD): $12.9B calculated opportunity across 4 products. - Slovenia (SVN): $12.8B calculated opportunity across 2 products. - Belgium (BEL): $11.4B calculated opportunity across 2 products. - Canada (CAN): $9.8B calculated opportunity across 6 products. - Spain (ESP): $8.6B calculated opportunity across 4 products. - France (FRA): $7.4B calculated opportunity across 5 products. - United Kingdom (GBR): $6.0B calculated opportunity across 3 products. - India (IND): $5.6B calculated opportunity across 6 products. ## Growth stars - HS 281820: +160.6% average CAGR, $1.1B calculated opportunity. - HS 382319: +62.6% average CAGR, $1.9B calculated opportunity. - HS 300215: +60.0% average CAGR, $24.9B calculated opportunity. - HS 294190: +57.4% average CAGR, $989.6M calculated opportunity. - HS 290110: +51.8% average CAGR, $3.8B calculated opportunity. - HS 290243: +26.5% average CAGR, $6.2B calculated opportunity. - HS 330300: +21.4% average CAGR, $5.0B calculated opportunity. - HS 290531: +16.7% average CAGR, $2.0B calculated opportunity. - HS 382200: +12.4% average CAGR, $6.4B calculated opportunity. - HS 293339: +12.3% average CAGR, $870.8M calculated opportunity. ## Diversification opportunities - HS 300490: 20 buyer markets, $113.7B calculated opportunity. - HS 382499: 10 buyer markets, $13.1B calculated opportunity. - HS 300215: 9 buyer markets, $24.9B calculated opportunity. - HS 300212: 4 buyer markets, $10.4B calculated opportunity. - HS 300439: 4 buyer markets, $7.2B calculated opportunity. - HS 330499: 4 buyer markets, $7.0B calculated opportunity. - HS 382200: 4 buyer markets, $6.4B calculated opportunity. - HS 330300: 3 buyer markets, $5.0B calculated opportunity. - HS 293499: 2 buyer markets, $5.5B calculated opportunity. - HS 290220: 2 buyer markets, $4.3B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.